TAIGEN BIOTECHNOLOGY CO., LTD.
- Country
- 🇹🇼Taiwan
- Ownership
- Public, Subsidiary
- Established
- 2001-05-01
- Employees
- 101
- Market Cap
- -
Oral Nemonoxacin in Treating Elderly Patients With CAP
- First Posted Date
- 2021-11-24
- Last Posted Date
- 2021-11-24
- Lead Sponsor
- TaiGen Biotechnology Co., Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT05133752
- Locations
- 🇨🇳
Tri-Service General Hospital, Taipei, Taiwan
To Evaluate the Efficacy and Safety of TG-1000 Compared With Placebo in Adult Patients With Acute Uncomplicated Influenza Virus Infection
- First Posted Date
- 2021-01-12
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- TaiGen Biotechnology Co., Ltd.
- Target Recruit Count
- 202
- Registration Number
- NCT04706468
- Locations
- 🇨🇳
Xiangya Hospital Central South University, Hunan, China
To Evaluate the Safety, Tolerability, and Pharmacokinetics Profiles of TG-1000 in Healthy Volunteers, and the Food Effect on Pharmacokinetics of Single Oral Dose of TG-1000 in Healthy Volunteers.
- First Posted Date
- 2020-07-31
- Last Posted Date
- 2021-01-07
- Lead Sponsor
- TaiGen Biotechnology Co., Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT04495322
- Locations
- 🇨🇳
Xiangya Hospital of Central South University, Changsha, Hunan, China
A Study Evaluating the Effect of a Single-dose Oral Administration of Nemonoxacin Capsule on QTc Intervals and Heart Rhythms of Healthy Subjects and the Influence of Food Intake on QTc Intervals and Pharmacokinetic Characteristics
- Conditions
- Interventions
- First Posted Date
- 2017-12-05
- Last Posted Date
- 2017-12-06
- Lead Sponsor
- TaiGen Biotechnology Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT03362853
Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection
- Conditions
- Interventions
- First Posted Date
- 2015-01-19
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- TaiGen Biotechnology Co., Ltd.
- Target Recruit Count
- 25
- Registration Number
- NCT02340962
- Locations
- 🇨🇳
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP
- Conditions
- Interventions
- First Posted Date
- 2014-07-31
- Last Posted Date
- 2021-10-25
- Lead Sponsor
- TaiGen Biotechnology Co., Ltd.
- Target Recruit Count
- 598
- Registration Number
- NCT02205112
- Locations
- 🇨🇳
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
🇨🇳Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
🇨🇳Taipei Medical University - Shuang Ho Hospital, Taipei, Taiwan
Study to Evaluate the PK, Relative Bioavailability and Safety of TG-2349 With Single Oral Dose Under Fed Condition in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2014-04-09
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- TaiGen Biotechnology Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02108418
- Locations
- 🇺🇸
WCCT, Cypress, California, United States
Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride
- Conditions
- Interventions
- First Posted Date
- 2013-09-18
- Last Posted Date
- 2015-02-18
- Lead Sponsor
- TaiGen Biotechnology Co., Ltd.
- Target Recruit Count
- 207
- Registration Number
- NCT01944774
- Locations
- 🇨🇳
Institute of Antibiotics, Huashan Hospital, Fundan University, Shanghai, China
🇨🇳Far eastern memorial hospital, Taipei, Taiwan
Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)
- Conditions
- Interventions
- First Posted Date
- 2012-02-23
- Last Posted Date
- 2018-01-24
- Lead Sponsor
- TaiGen Biotechnology Co., Ltd.
- Target Recruit Count
- 192
- Registration Number
- NCT01537250
- Locations
- 🇨🇳
Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
🇨🇳Beijing Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China
🇨🇳Peking University First Hospital, Beijing, China
A Study of Nemonoxacin Malate Sodium Chloride Injection Administered by Intravenous Infusion
- First Posted Date
- 2012-02-09
- Last Posted Date
- 2012-02-20
- Lead Sponsor
- TaiGen Biotechnology Co., Ltd.
- Target Recruit Count
- 176
- Registration Number
- NCT01529957
- Locations
- 🇨🇳
Guangzhou Red Cross Hospital, Guangzhou, China
🇨🇳Third Military Medical University, Third Affiliated Hospital, Chongqing, China
🇨🇳Zhen Hospital, Capital Medical University Beijing, Beijing, China